Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Sep 1;74(9):971-972.
doi: 10.1001/jamapsychiatry.2017.1776.

Ketamine for the Treatment of Depression-Reply

Gerard Sanacora  1
Affiliations
Comment

Ketamine for the Treatment of Depression-Reply

Gerard Sanacora. JAMA Psychiatry. .
No abstract available

PubMed Disclaimer

Comment on

  • A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
    Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. Sanacora G, et al. JAMA Psychiatry. 2017 Apr 1;74(4):399-405. doi: 10.1001/jamapsychiatry.2017.0080. JAMA Psychiatry. 2017. PMID: 28249076 Review.
  • Ketamine for the Treatment of Depression.
    Golzari SEJ, Mahmoodpoor A. Golzari SEJ, et al. JAMA Psychiatry. 2017 Sep 1;74(9):971. doi: 10.1001/jamapsychiatry.2017.1779. JAMA Psychiatry. 2017. PMID: 28700777 No abstract available.
  • Ketamine for the Treatment of Depression.
    Rasmussen KG. Rasmussen KG. JAMA Psychiatry. 2017 Sep 1;74(9):970-971. doi: 10.1001/jamapsychiatry.2017.1773. JAMA Psychiatry. 2017. PMID: 28700782 No abstract available.
  • Ketamine for the Treatment of Depression.
    Kraus C, Lanzenberger R, Kasper S. Kraus C, et al. JAMA Psychiatry. 2017 Sep 1;74(9):970. doi: 10.1001/jamapsychiatry.2017.1770. JAMA Psychiatry. 2017. PMID: 28700802 No abstract available.